Health & Environmental Research Online (HERO)


Print Feedback Export to File
508408 
Journal Article 
Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer 
Pampalakis, G; Sotiropoulou, G 
2007 
1776 
1 
22-31 
English 
Human tissue kallikreins (KLKs or kallikrein-related peptidases) are a subgroup of extracellular serine proteases that act on a wide variety of physiological substrates, while they display aberrant expression patterns in certain types of cancer. Differential expression patterns lead to the exploitation of these proteins as new cancer biomarkers for hormone-dependent malignancies, in particular. The prostate-specific antigen or kallikrein-related peptidase 3 (PSA/KLK3) is an established tumor marker for the diagnosis and monitoring of prostate cancer. It is well documented that specific KLK genes are co-expressed in tissues and in various pathologies suggesting their participation in complex proteolytic cascades. Here, we review the currently established knowledge on the involvement of KLK proteolytic cascades in the regulation of physiological and pathological processes in prostate tissue and in skin. It is well established that the activity of KLKs is often regulated by auto-activation and subsequent autolytic internal cleavage leading to enzymatic inactivation, as well as by inhibitory serpins or by allosteric inhibition by zinc ions. Redistribution of zinc ions and alterations in their concentration due to physiological or pathological reasons activates specific KLKs initiating the kallikrein cascade(s). Recent studies on kallikrein substrate specificity allowed for the construction of a kallikrein interaction network involved in semen liquefaction and prostate cancer, as well as in skin pathologies, such as skin desquamation, psoriasis and cancer. Furthermore, we discuss the crosstalks between known proteolytic pathways and the kallikrein cascades, with emphasis on the activation of plasmin and its implications in prostate cancer. These findings may have clinical implications for the underlying molecular mechanism and management of cancer and other disorders in which KLK activity is elevated. (c) 2007 Elsevier B.V. All rights reserved. 
human tissue kallikreins; proteolytic cascades; prostate cancer; semen; liquefaction; skin desquamation; skin cancer; prostate-specific antigen; human glandular kallikrein; human seminal; plasma; protein-c inhibitor; growth-factor-beta; nipple aspirate fluid; serine-protease; stratum-corneum; plasminogen-activator; netherton-syndrome